|
Originally published In Press as doi:10.1074/jbc.M201903200 on April 8, 2002
J. Biol. Chem., Vol. 277, Issue 24, 21537-21541, June 14, 2002
Chemotactic Factor-induced Recruitment and Activation of Tec
Family Kinases in Human Neutrophils
IMPLICATION OF PHOSPHATIDYLINOSITOL 3-KINASES*
Geneviève
Lachance,
Sylvain
Levasseur, and
Paul H.
Naccache
From the Canadian Institutes for Health Research Group on the
Molecular Mechanisms of Inflammation, Centre de recherche en
rhumatologie et immunologie, Centre de recherche du Centre Hospitalier
de l'Université Laval, Department of Medicine, Laval University,
Québec G1V 4G2, Canada
Received for publication, February 26, 2002, and in revised form, March 28, 2002
 |
ABSTRACT |
The importance of the tyrosine phosphorylation
cascades in the initiation and regulation of the functional
responsiveness of human neutrophils is well established. On the other
hand, the link between the G protein-coupled receptors (to which the
receptors for chemotactic factors belong) and the activation of
tyrosine kinases is very poorly characterized. Based on previous
observations indicating that the stimulation of tyrosine
phosphorylation was sensitive to inhibition by the phosphatidylinositol
3-kinase inhibitor wortmannin and the recent description of
pleckstrin homology domain-containing tyrosine kinases (the Tec
family), we have examined the potential implication of the latter in
the responses of human neutrophils to chemotactic factors. The results
obtained indicate firstly that several members of the Tec family of
tyrosine kinases are expressed in human neutrophils, including Tec,
Btk, and Bmx. Stimulation of the cells with fMet-Leu-Phe led to a rapid
activation of Tec as indicated by its translocation to a membrane
fraction and to increases in its in situ level of tyrosine
phosphorylation and its capacity to tyrosine phosphorylate itself or an
exogenous substrate (SAM68-GST) in in vitro kinase assays.
The activation of Tec was inhibited by pertussis toxin as well as by
wortmannin. The results of this study provide direct evidence for the
implication of Tec family kinases in the responses of human neutrophils
to chemotactic factors. They also suggest that one of the links between G protein-coupled receptors and tyrosine kinases depends on the activation of phosphatidylinositol 3-kinase and the generation of
phosphatidylinositol 3,4,5-trisphosphate.
 |
INTRODUCTION |
Stimulation of human polymorphonuclear neutrophil leukocytes
(neutrophils) by chemoattractants is accompanied by a distinct tyrosine
phosphorylation signature (1). The functional significance of this
response has been established using a variety of tyrosine kinase
inhibitors that have been shown to negatively modulate various
responses to these agonists including adherence and locomotion (2) and
the stimulation of the NADPH oxidase (3-6). Additionally, the
stimulation of several tyrosine kinases following the ligation of
chemoattractant receptors has also been reported (7-14). Finally, the
absence of Src kinases in mice knock-out models has been shown to
result in impaired signaling and responsiveness in neutrophils (15,
16).
Chemoattractant receptors, including those to chemokines and to lipid
mediators, belong to the superfamily of G protein-coupled receptors
(17-19). Accordingly, the stimulation of the tyrosine phosphorylation
induced by the occupation of these receptors is known to be sensitive
to inhibition by pertussis toxin (1). The steps that follow the
activation of the G proteins (presumably members of the
Gi subfamily) and link them to the modulation of the
activity of tyrosine kinases and phosphatases remain undefined despite
the critical importance of this knowledge to the development of a
complete understanding of G protein-coupled receptor signaling and of
the regulation of the functional responsiveness of human neutrophils.
The results of a previous study have provided evidence that the
stimulation of tyrosine phosphorylation by chemoattractants in human
neutrophils was sensitive to the phosphatidylinositol 3-kinase (PI 3-kinase)1
inhibitor, wortmannin (20). This observation was originally difficult
to reconcile with the characteristics of PI 3-kinases known at the
time, which were themselves controlled by the tyrosine phosphorylation
of their regulatory p85 subunit (21). Since then, the existence of a G
protein-dependent PI 3-kinase isoform, p110 , has been
established (22, 23). Its presence and activation in human neutrophils,
in preference over that of p85/p110, by chemoattractants has also been
reported (24).
The end result of the activation of PI 3-kinases in
situ is the generation of phosphatidylinositol (3, 4,
5)-trisphosphate (PtdIns(3,4,5)P3) (25, 26). The recent
characterization of a novel family of tyrosine kinases containing PH
domains, the Tec family (27-32), provided a potential novel link
between the PI 3-kinase and the tyrosine
phosphorylation-dependent pathways. This hypothesis was
corroborated in several tyrosine kinase-dependent systems including the T cell receptor, the B cell receptor, and CD32 in which the activation of various members of the Tec family was
found to be secondary to that of the p85/p110 PI 3-kinase (33-44). The
report of the involvement of Btk in thrombin-stimulated platelets (45,
46) represents the only evidence of the relationship of the Tec family
of tyrosine kinases with the activation of G protein-coupled receptors
to date.
The present investigation was initiated to examine the possible
involvement of Tec family kinases in the responses of human neutrophils
to chemotactic factors. The results obtained demonstrate that several
Tec family kinases are expressed in mature blood neutrophils
(Tec, Btk, Bmx). Stimulation of human neutrophils by chemotactic
factors led to the G protein- and PI 3-kinase-dependent activation of multiple members of the Tec family kinases. These results
provide evidence for a novel pathway linking chemotactic factor
receptors of the G protein-coupled family to downstream tyrosine
phosphorylation-dependent signaling events.
 |
MATERIALS AND METHODS |
Antibodies--
Anti-Bmx (N-16), anti-Btk (C-20), and anti-Tec
(M-20) and immunizing peptides were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). Anti-Tec (06-561), used for
immunoprecipitations, and anti-phosphotyrosine (05-321, clone 4G10)
were obtained from Upstate Biotechnology, Inc (Lake Placid, NY).
Reagents--
ATP magnesium salt,
diisopropylfluorophosphate (DFP), phenylmethylsulfonyl fluoride (PMSF),
Me2SO, fMet-Leu-Phe, and wortmannin were from Sigma. The
enhanced chemiluminescence reagents used for Western blotting
were purchased from DuPont Pharmaceuticals (Missisauga, Ontario,
Canada). Dextran T-500, glutathione-Sepharose, and protein
A-Sepharose were obtained from Amersham Biosciences. Ficoll-Paque and
Mg2+-free Hanks' balanced salt solution were from Wisent
Canadian Laboratories (St. Bruno, Québec, Canada), and
pertussis toxin was from List Biologicals (Campbell, CA). CHAPS
was obtained from Roche Molecular Biochemicals. SAM68-GST (sc-4249) was
obtained from Santa Cruz Biotechnology.
Neutrophil Purification--
Venous blood was collected in
isocitrate anticoagulant from healthy adult volunteers, and neutrophils
were purified sterilely as described previously (47). Neutrophils at
2 × 107 cells/ml were resuspended in Hanks' balanced
salt solution containing 1.6 mM CaCl2 but no
magnesium and pretreated with 1 mM DFP for 10 min at room
temperature before any additional manipulation.
Immunoblotting--
Neutrophil suspensions (250 µl of 2 × 107 cells/ml) were added to an equal volume of boiling
2× Laemmli sample buffer (1× is 62.5 mM Tris-HCl, pH 6.8, 4% SDS, 5% -mercaptoethanol, 8.5% glycerol, 2.5 mM
orthovanadate, 10 mM paranitrophenylphosphate, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 0.025% bromphenol blue) and boiled for 7 min. Samples were then subjected to 8% SDS-polyacrylamide gel
electrophoresis and transferred to Immobilon polyvinylidene difluoride
membranes (Millipore Corp., Bedford, MA). Immunoblotting was performed
using anti-Bmx (1/1000), anti-Btk (1/1000), and anti-Tec
(1/1000) in Tris-buffered saline/Tween with 2% gelatin.
Immunoprecipitation under Native Conditions--
After
stimulation, neutrophils were centrifuged, and the cell pellets were
lysed by adding cold lysis buffer (10 mM Tris-HCl, pH 7.4, 137.2 mM Nacl, 1 mM EDTA, 0.6% CHAPS, 2 mM orthovanadate, 10 µg/ml leupeptin, 10 µg/ml
aprotinin, 50 µg/ml soybean trypsin inhibitor, 1 mM PMSF,
1.5 mM DFP) for 3 min on ice. The insoluble material was
discarded after centrifugation at 13,000 × g at
4 °C during 10 min, and the lysate was harvested. The supernatants were precleared with protein A-Sepharose at 4 °C for 30 min. The lysates were then incubated at 4 °C with 4 µg of anti-Tec
antibodies for 2 h followed by 1 h incubation with protein
A-Sepharose beads. The beads were collected and washed three times with
cold lysis buffer. Laemmli sample buffer (2×) was added to the beads,
which were boiled for 7 min.
In Vitro Autophosphorylation Assay--
Neutrophils (2 × 107 cells/ml) were stimulated for 60 s with
10 7 M fMet-Leu-Phe. Tec was then
immunoprecipitated as described above. The Tec immunoprecipitates were
washed three times in lysis buffer, resuspended at 4 °C in kinase
buffer (50 mM HEPES, pH 7.6, 10 mM
MnCl2, 2 mM MgCl2, 1 mM
paranitrophenylphosphate, and 50 µM ATP) and transferred
at 37 °C for different times. The reactions were stopped by a quick
spin in a microcentrifuge, and the beads were washed twice in cold
lysis buffer. Laemmli sample buffer (2×) was added to the beads, which
were boiled for 7 min. The samples were then electrophoresed and
transferred to Immobilon polyvinylidene difluoride membranes, which
were blotted with the anti-phosphotyrosine or with the anti-Tec antibodies.
In Vitro Kinase Activity toward SAM68-GST--
This assay was
carried out exactly like the in vitro autophosphorylation
assay described above except that 0.5 µg of SAM68-GST was added to
the kinase buffer. The supernatants of the kinase assays were collected
and incubated for 1 h at 4 °C in lysis buffer in 1:2
proportions with glutathione-Sepharose beads. The glutathione-Sepharose beads were washed twice and boiled for 7 min in Laemmli sample buffer
(2×). The samples were then electrophoresed and transferred to
Immobilon polyvinylidene difluoride membranes, which were blotted with
the anti-phosphotyrosine or with the anti-Tec antibodies.
Membrane Preparation and Translocation Assays--
Neutrophils
(500 µl at 4 × 107 cells/ml) were incubated or not
with 200 nM wortmannin for 10 min or 1 µg/ml pertussis
toxin for 2 h. The cell suspensions were prewarmed at 37 °C for
5 min and stimulated with 10 7 M fMet-Leu-Phe
or an equal volume of diluent (Me2SO) for different times.
Stimulations were stopped by sonication for 20 s. One ml of cold
KCl-HEPES relaxation buffer (100 mM KCl, 50 mM
HEPES, 5 mM NaCl, 1 mM MgCl2, 0.5 mM EGTA, 5 µg/ml aprotinin, 5 µg/ml leupeptin, 1 mM orthovanadate, 2.5 mM PMSF, 1 mM
DFP, pH 7.2) was added rapidly. The lysates were centrifuged for 10 min
at 13,000 × g. Unbroken cells and nuclei were
discarded, and supernatants were then ultracentrifuged for 45 min at
180,000 × g in a Beckman TL-100 ultracentrifuge using
a TL-100.4 rotor. The membrane pellets were resuspended in 80 µl of
solubilization buffer (250 mM phosphate buffer, pH 6.8, 300 mM NaCl, 2.5% SDS, 0.25 mM PMSF, 5 µg/ml
aprotinin, 5 µg/ml leupeptin, 1 mM orthovanadate). 5 µl
of each sample was discarded for protein quantification, and 75 µl of
2× Laemmli sample buffer was added to each sample and boiled for 7 min. Proteins were quantified by enzyme-linked immunosorbent assay with
Coomassie protein assay reagent (Pierce). 10 µg of each condition was
subjected to 8% SDS-polyacrylamide gel electrophoresis and transferred
to Immobilon polyvinylidene difluoride membranes.
 |
RESULTS |
Presence of Tec Family Members in Human Neutrophils--
As
of yet, the only evidence for the expression in granulocytes of Tec
family members is that of the mRNA for Bmx, one member of this
family of kinases (48, 49). The data shown in Fig. 1 illustrate that Tec, Bmx, and Btk are
expressed at the protein level in human peripheral blood neutrophils.
These immunoblots indicate that specific staining of proteins of
the expected apparent molecular weight was seen with the three
antibodies and that this staining was displaced by the appropriate
immunizing peptides. It should be noted that two isoforms of Tec were
detected with apparent molecular masses of 58 and 66 kDa.
Alternatively spliced Tec isoforms of these molecular weights have been
described previously (31).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Presence of Tec family kinases in human
neutrophils. Whole neutrophil extracts were processed for
immunoblotting as described under "Materials and Methods." The
membranes were blotted with the indicated antibodies, preneutralized
(+) or not ( ) with the immunizing peptides. The data shown are from a
representative experiment, repeated at least three times, with
identical results, on separate cell preparations.
|
|
Activation of Tec Family Members by Chemotactic Factors in Human
Neutrophils--
One of the characteristic features of the activation
of Tec family tyrosine kinases is their stimulated translocation to
membrane fractions, an event that is thought to result from high
affinity interactions of their PH domains with
PtdIns(3,4,5)P3 (27, 28, 50, 51). We had shown previously
that the stimulation of human neutrophils by chemotactic factors was
associated with the translocation of p110 to a crude membrane
fraction (24). We therefore examined whether the distribution of Tec
family kinases in this fraction was altered upon stimulation of
neutrophils by fMet-Leu-Phe. The results of these experiments are
illustrated in Fig. 2. The chemotactic factor was found to induce a rapid translocation of the 66-kDa isoform of Tec which was evident within 5 s of stimulation with fMet-Leu-Phe. Maximal levels of membrane-associated Tec were reached at
10-15 s post-stimulation (Fig. 2, panel A). It should be
noted that the 58-kDa isoform of Tec did not appear to be sensitive to
stimulation by fMet-Leu-Phe as its distribution in the membrane fraction did not change upon stimulation. Equivalent translocations of
Btk and Bmx were also observed (Fig. 2, panels B and
C). Preliminary experiments indicated that interleukin-8
also induced a translocation of Tec, Btk, and Bmx to the membrane
fraction (data not shown).

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 2.
Stimulated translocation of Tec family
kinases upon stimulation by fMet-Leu-Phe (fMLP) in
human neutrophils. Neutrophil suspensions were stimulated with
10 7 M fMet-Leu-Phe for the time indicated in
the legends in the figures, following which the cells were
processed for membrane preparation and immunoblotting as detailed under
"Materials and Methods." The data shown are from two separate
representative experiments, each repeated at least three times, with
identical results, on separate cell preparations.
|
|
The translocation of Tec family kinases to the membrane fraction
induced by stimulation by fMet-Leu-Phe was sensitive to inhibition by
pertussis toxin (Fig. 3). Preincubation
of the cells with the bacterial toxin decreased to a large extent the
stimulated increases in the levels of Tec, Bmx, and Btk that could
otherwise be detected in the membrane fractions derived from
fMet-Leu-Phe-stimulated cells.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
Pertussis toxin sensitivity of the
translocation of Tec family kinases induced by fMet-Leu-Phe. In
these experiments, the cells (107 cells/ml) were incubated
with 1 µg/ml pertussis toxin for 2 h in the presence of 1 mg/ml
bovine serum albumin before being stimulated with fMet-Leu-Phe for the
indicated times as indicated under "Materials and Methods." The
data shown are from two separate representative experiments, each
repeated at least three times, with identical results, on separate cell
preparations.
|
|
Another index of the activation of tyrosine kinases is their level of
in situ tyrosine phosphorylation. The latter can be increased upon stimulation due to autophosphorylation events or secondarily to transphosphorylation by other tyrosine kinases (31). The
data shown in Fig. 4, panel A,
indicate that stimulation of human neutrophils by fMet-Leu-Phe led to
the in situ phosphorylation of Tec. This phosphorylation was
detected within 5-15 s of the addition of fMet-Leu-Phe and was
maintained for the next 60 s. A similar increase in the tyrosine
phosphorylation of Btk was also observed (results not shown). The
inability of the available anti-Bmx antibodies to precipitate Bmx
(under native or denaturing conditions) prevented us from determining
whether the latter was similarly affected upon the stimulation of the
cells (data not shown).

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 4.
Phosphorylation status and enzymatic activity
of Tec in fMet-Leu-Phe-stimulated human neutrophils.
Neutrophil suspensions were stimulated with fMet-Leu-Phe
(10 7 M) for the indicated times
(A). They were then lysed under native conditions, Tec was
immunoprecipitated, and the precipitates were processed for
immunoblotting (IB) with anti-phosphotyrosine (upper
panel) or anti-Tec antibodies as described under "Materials and
Methods." Neutrophil suspensions were stimulated with fMet-Leu-Phe
(10 7 M) for 1 min (B). They were
then lysed under native conditions, Tec was immunoprecipitated, and the
precipitates were transferred to a kinase buffer as described under
"Materials and Methods," and the assays were carried out for the
indicated times. The level of tyrosine phosphorylation of Tec was then
monitored by immunoblotting. The membranes were reblotted with an
anti-Tec antibody. Neutrophil suspensions were stimulated with
fMet-Leu-Phe (10 7 M) for 1 min
(C). They were then lysed under native conditions, Tec was
immunoprecipitated, and the precipitates were transferred to a kinase
buffer to which SAM68-GST was added as described under "Materials and
Methods," and the assays were carried out for the indicated times.
SAM68-GST was then isolated, and its level of tyrosine phosphorylation
was monitored as described under "Materials and Methods." The
membranes were reblotted with an anti-SAM68 antibody. The data shown
are from three separate representative experiments, each repeated at
least three times, with identical results, on separate cell
preparations.
|
|
We examined next whether the translocation of Tec and the stimulation
of its in situ levels of tyrosine phosphorylation were associated with an increase in kinase activity. Neutrophils were stimulated with fMet-Leu-Phe for 60 s and lysed under native
conditions as described under "Materials and Methods," and Tec was
immunoprecipitated. The immunoprecipitates were then resuspended in
kinase buffer, and the kinase activity of Tec was monitored by its
ability to phosphorylate itself (Fig. 4, panel B) or an
exogenous substrate, SAM68-GST (Fig. 4, panel C). The latter
was chosen as it has previously been shown to associate with members of
the Tec family of tyrosine kinases (52, 53). The results of these
experiments, illustrated in Fig. 4, panels B and
C, show that stimulation of neutrophils by fMet-Leu-Phe
increased the activity of Tec toward itself as well as toward SAM68-GST
as evidenced by a time-dependent increase in tyrosine phosphorylation.
PI 3-Kinase Dependence of the Activation of Tec Family Tyrosine
Kinases by Chemotactic Factors--
The pertussis toxin sensitivity of
the stimulated translocation of Tec, Btk, and Bmx indicated that the
recruitment of these kinases was secondary to the activation of
heterotrimeric G proteins. To test whether this response was up- or
downstream of the activation of PI 3-kinases, we examined next whether
it was affected by preincubation of the cells with the PI 3-kinase
inhibitor wortmannin. In these experiments, neutrophils were pretreated
for 10 min with 200 nM wortmannin and then stimulated with
fMet-Leu-Phe. The effects of wortmannin on the stimulated translocation
of Tec are illustrated in Fig. 5,
panel A. The results of these experiments demonstrate that
wortmannin inhibited to a significant extent the ability of the
chemotactic factor to increase the levels of the 66-kDa isoform of Tec
associated with membranes. Similar results were obtained with Btk and
Bmx (data not shown). Wortmannin also inhibited the
increased in situ phosphorylation of Tec as well as the
in vitro activity of Tec toward itself and SAM68-GST
observed following the addition of fMet-Leu-Phe to neutrophils (Fig. 5,
panels B-D, respectively).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
Wortmannin sensitivity of the activation of
Tec by fMet-Leu-Phe in human neutrophils. Neutrophil suspensions
were pretreated or not with wortmannin for 10 min as indicated. They
were then stimulated with fMet-Leu-Phe (10 7
M) for 1 min following which the membrane translocation,
in situ phosphorylation, and in vitro
autophosphorylation and tyrosine kinase activity toward SAM68-GST were
monitored as described under "Materials and Methods" using a 3-min
incubation during the kinase assays. The data shown are from three
separate representative experiments, each repeated at least three
times, with identical results, on separate cell preparations.
IP, immunoprecipitation.
|
|
 |
DISCUSSION |
Tyrosine phosphorylation-dependent signaling cascades
play critical roles in the initiation and regulation of the activation of various cell types including that of peripheral blood human neutrophils. The results of the present investigation provide direct
evidence for a participation of Tec family kinases in the initial
events leading to the activation of the tyrosine phosphorylation signaling pathways in human neutrophils. The recruitment and activation of the Tec kinases was also found to be secondary to the activation of
heterotrimeric G proteins and PI 3-kinases.
Various lines of evidence have accumulated during the last decade in
support of the role of the tyrosine phosphorylation cascade in the
initiation of the functional responsiveness of human neutrophils (see
references in the introduction). These include the demonstration of the
presence and activation of several classes of tyrosine kinases (54) and
phosphatases (55) upon the stimulation of neutrophils by a variety of
agonists. This results in a transient increase in the overall level of
tyrosine phosphorylation in these cells due to the phosphorylation of a
large number of substrates, only some of which have been identified.
Additional support for the functional relevance of these biochemical
responses was derived from the effects of tyrosine kinase inhibitors,
which dramatically affect several critical neutrophil responses such as
adhesion, chemotaxis, superoxide generation, and phagocytosis. Finally, knock-out cell lines have provided further confirmation of the role of
various tyrosine kinases in the regulation of neutrophil responsiveness
in addition to identifying relevant kinase families and
establishing the redundant nature of several of these kinases, and in particular, the members of the Src family.
Neutrophil function is critically dependent on their migration to the
proper sites (infection, injury). This directed locomotion is dictated
by the generation of gradients of a series of chemotactic factors. The
latter interact for the most part with members of the G
protein-coupled, seven-transmembrane-spanning surface receptors. All of
the known neutrophil chemotactic factors stimulate an increase in the
level of tyrosine phosphorylation in these cells (1). This response is
known to be mediated by heterotrimeric G proteins as it is inhibited by
pertussis toxin. On the other hand, little else is known about the
steps that couple the relevant G protein to the tyrosine
phosphorylation cascade.
Possible clues as to one such coupling mechanism were provided by the
observations that the PI 3-kinase inhibitor wortmannin significantly
decreased the level of tyrosine phosphorylation induced by the
chemotactic peptide fMet-Leu-Phe (20), by the recent cloning and
characterization of a G protein-linked PI 3-kinase isoform (p110 )
(22, 23) responsive to stimulation by fMet-Leu-Phe (24), and by the
identification of a PH domain-containing tyrosine kinase family (the
Tec kinases) (27-32).
The present data indicate that several members of the Tec family are
expressed in human neutrophils. Immunoblotting revealed the presence of
Btk, Bmx, and two isoforms of Tec. Preliminary experiments indicated
that Rlk/Txk was not expressed in human neutrophils (data not shown).
The presence of Itk in human neutrophils was not investigated. Several
indices of activation of Tec kinases by fMet-Leu-Phe were obtained.
These include the stimulated translocation to a membrane fraction of
all but the low molecular weight Tec isoform (which was constitutively
present to a significant extent in this fraction) and the increased
in situ levels of tyrosine phosphorylation and in
vitro kinase activity of the high molecular weight isoform of Tec
and of Btk (data not shown). Taken together, these data provide strong
and direct evidence for an involvement of these kinases in the
responses of human neutrophils to chemotactic factors.
Of particular relevance to the specific hypothesis tested in this
study, wortmannin inhibited all three indices of activation of Tec
kinases by fMet-Leu-Phe. These data suggest that the recruitment and
stimulation of Tec kinases by fMet-Leu-Phe was secondary to the
activation of PI 3-kinases. In view of the facts that Tec kinases are
unique among tyrosine kinases in that they contain a PH domain and that
the PH domains of Btk (28, 50) and Tec (56) exhibit a high degree of
specificity toward PtdIns(3,4,5)P3, it is tempting to
speculate that the membrane recruitment of the Tec kinases stimulated
by fMet-Leu-Phe is a consequence of the activation of PI 3-kinase(s)
and the formation of PtdIns(3,4,5)P3.
It is noteworthy in this respect to point out that stimulation of human
neutrophils causes a very rapid formation of
PtdIns(3,4,5)P3 (25, 26). Furthermore, data were recently
obtained indicating that, at least within the time frame examined in
the present study (i.e. the first 15 s), p110 was
the predominant PI 3-kinase species activated by fMet-Leu-Phe (24). The
kinetics of the activation of p110 , of the formation of
PtdIns(3,4,5)P3, and of the Tec kinases are
strikingly similar, and all three of these are close to maximal within
5-10 s of the addition of chemotactic factors. Although not a proof
that a direct causal relationship exists between the activation of
p110 and of Tec kinases, these data are nevertheless consistent with
such an interpretation. In the absence of specific inhibitors of the
different isoforms of PI 3-kinases, additional direct support for this
hypothesis is likely to have to rely on the use of dominant negative
mutants of the individual PI 3-kinases, a task that is particularly
difficult in the terminally differentiated human neutrophils.
The above data are consistent with the previously reported inhibition
of neutrophil chemotaxis by PI 3-kinase inhibitors such as wortmannin
and LY294002 (57-61) and the observation that neutrophil recruitment
into inflammatory sites was defective in p110 knock-out mice
(62-64). They suggest that these findings may be accommodated by a
model in which Tec kinases play a role downstream from the activation
of p110 .
In summary then, the results of the present data provided direct
evidence for an involvement of Tec family tyrosine kinases in the
responses of human neutrophils to chemotactic factors. The recruitment
and activation of Tec kinases was found to be dependent on PI 3-kinase
activity. These results shed new light on the link between the
activation of G protein-coupled receptors to the tyrosine
phosphorylation-dependent signaling pathways, a poorly
understood element of cell biology.
 |
FOOTNOTES |
*
This work was supported in part by grants from the Canadian
Institutes for Health Research.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: CHUL du CHUQ, Room T
1-49, 2705 Blvd. Laurier, Québec, Québec G1V 4G2, Canada. Tel: 418-654-2772; Fax: 418-654-2765; E-mail:
paul.naccache@crchul. ulaval.ca.
Published, JBC Papers in Press, April 8, 2002, DOI 10.1074/jbc.M201903200
 |
ABBREVIATIONS |
The abbreviations used are:
PI 3-kinase, phosphatidylinositol 3-kinase;
PtdIns(3, 4,5)P3,
phosphatidylinositol (3, 4, 5)-trisphosphate;
PH, pleckstrin homology;
DFP, diisopropylfluorophosphate;
CHAPS, 3-[(3-Cholamidopropanyl)
dimethyl-ammonio]-1-propanesulfonate;
PMSF, phenylmethylsulfonyl
fluoride;
GST, glutathione S-transferase.
 |
REFERENCES |
| 1.
|
Rollet, E.,
Caon, A. C.,
Roberge, C. J.,
Liao, N. W.,
Malawista, S. E.,
McColl, S. R.,
and Naccache, P. H.
(1994)
J. Immunol.
153,
353-363[Abstract]
|
| 2.
|
Gaudry, M.,
Caon, A. C.,
Gilbert, C.,
Lille, S.,
and Naccache, P. H.
(1991)
J. Leukocyte Biol.
51,
103-108
|
| 3.
|
Gomez-Cambronero, J.,
Wang, E.,
Johnson, G.,
Huang, C.-K.,
and Sha'afi, R. I.
(1991)
J. Biol. Chem.
266,
6240-6245[Abstract/Free Full Text]
|
| 4.
|
Fialkow, L.,
Chan, C. K.,
Grinstein, S.,
and Downey, G. P.
(1993)
J. Biol. Chem.
268,
17131-17137[Abstract/Free Full Text]
|
| 5.
|
Gomez-Cambronero, J.,
Huang, C. K.,
Bonak, V. A.,
Wang, E.,
Casnellie, J. E.,
Shiraishi, T.,
and Sha'afi, R. I.
(1989)
Biochem. Biophys. Res. Commun.
162,
1478-1485[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Grinstein, S.,
and Furuya, W.
(1991)
Am. J. Physiol.
260,
C1019-C1027[Medline]
[Order article via Infotrieve]
|
| 7.
|
Lu, D. J.,
Furuya, W.,
and Grinstein, S.
(1993)
Blood Cells
19,
343-351[Medline]
[Order article via Infotrieve]
|
| 8.
|
Gaudry, M.,
Gilbert, C.,
Barabé, F.,
Poubelle, P. E.,
and Naccache, P. H.
(1995)
Blood
86,
3567-3574[Abstract/Free Full Text]
|
| 9.
|
Berkow, R. L.,
and Dodson, R. W.
(1991)
J. Leukocyte Biol.
49,
599-604[Abstract]
|
| 10.
|
Welch, H.,
and Maridonneau-Parini, I.
(1997)
Oncogene
15,
2021-2029[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Miura, Y.,
Tohyama, Y.,
Hishita, T.,
Lala, A.,
DeNardin, E.,
Yoshida, Y.,
Yamamura, H.,
Uchiyama, T.,
and Tohyama, K.
(2000)
Blood
96,
1733-1739[Abstract/Free Full Text]
|
| 12.
|
Welch, H.,
and Maridonneau-Parini, I.
(1997)
J. Biol. Chem.
272,
102-109[Abstract/Free Full Text]
|
| 13.
|
Berton, G.,
Fumagalli, L.,
Laudanna, C.,
and Sorio, C.
(1994)
J. Cell Biol.
126,
1111-1121[Abstract/Free Full Text]
|
| 14.
|
Yan, S. R.,
and Novak, M. J.
(1999)
FEBS Lett.
451,
33-38[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Mocsai, A.,
Jakus, Z.,
Vantus, T.,
Berton, G.,
Lowell, C. A.,
and Ligeti, E.
(2000)
J. Immunol.
164,
4321-4331[Abstract/Free Full Text]
|
| 16.
|
Lowell, C. A.,
and Berton, G.
(1999)
J. Leukocyte Biol.
65,
313-320[Abstract]
|
| 17.
|
Murphy, P. M.
(1997)
Semin. Hematol.
34,
311-318[Medline]
[Order article via Infotrieve]
|
| 18.
| Gerard, C., and Gerard, N. P. (1994) Annu. Rev.
Immunol.
|
| 19.
|
Prossnitz, E. R.,
and Ye, R. D.
(1997)
Pharmacol. Ther.
74,
73-102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Naccache, P. H.,
Caon, A. C.,
Gilbert, C.,
Gaudry, M.,
Roberge, C. J.,
Poubelle, P. E.,
and Bourgoin, S.
(1993)
Lab. Invest.
69,
19-23[Medline]
[Order article via Infotrieve]
|
| 21.
|
Funaki, M.,
Katagiri, H.,
Inukai, K.,
Kikuchi, M.,
and Asano, T.
(2000)
Cell. Signal.
12,
135-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Stoyanov, B.,
Volinia, S.,
Hanck, T.,
Rubio, I.,
Loubtchenkov, M.,
Malek, D.,
Stoyanova, S.,
Van-Haesebroeck, B.,
Dhand, R.,
Nurnberg, B.,
Gierschik, P.,
Seedorf, K.,
Hsuan, J. J.,
Waterfield, M. D.,
and Wetzker, R.
(1995)
Science
269,
690-693[Abstract/Free Full Text]
|
| 23.
|
Stephens, L.,
Smrcka, A.,
Cooke, F. T.,
Jackson, T. R.,
Sternweis, P. C.,
and Hawkins, P. T.
(1994)
Cell
77,
83-93[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Naccache, P. H.,
Levasseur, S.,
Lachance, G.,
Chakravarti, S.,
Bourgoin, S. G.,
and McColl, S. R.
(2000)
J. Biol. Chem.
275,
23636-23641[Abstract/Free Full Text]
|
| 25.
|
Traynor-Kaplan, A. E.,
Thompson, B. L.,
Harris, A. L.,
Taylor, P.,
Omann, G. M.,
and Sklar, L. A.
(1989)
J. Biol. Chem.
264,
15668-15673[Abstract/Free Full Text]
|
| 26.
|
Stephens, L. R.,
Hughes, K. T.,
and Irvine, R. F.
(1991)
Nature
351,
33-39[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Kojima, T.,
Fukuda, M.,
Watanabe, Y.,
Hamazato, F.,
and Mikoshiba, K.
(1997)
Biochem. Biophys. Res. Commun.
236,
333-339[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Okoh, M. P.,
and Vihinen, M.
(1999)
Biochem. Biophys. Res. Commun.
265,
151-157[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Mano, H.
(1999)
Int. J. Hematol.
69,
6-12[Medline]
[Order article via Infotrieve]
|
| 30.
|
Mano, H.
(1999)
Cytokine Growth Factor Rev.
10,
267-280[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Yang, W. C.,
Collette, Y.,
Nunes, Y.,
and Olive, D.
(2000)
Immunity
12,
373-382[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Yang, W. C.,
Ching, K. A.,
Tsoukas, C. D.,
and Berg, L. J.
(2001)
J. Immunol.
166,
387-395[Abstract/Free Full Text]
|
| 33.
|
Yoshida, K.,
Yamashita, Y.,
Miyazato, A.,
Ohya, K.,
Kitanaka, A.,
Ikeda, U.,
Shimada, K.,
Yamanaka, T.,
Ozawa, K.,
and Mano, H.
(2000)
J. Biol. Chem.
275,
24945-24952[Abstract/Free Full Text]
|
| 34.
|
Lu, Y. L.,
Cuevas, B.,
Gibson, S.,
Khan, H.,
LaPushin, R.,
Imboden, J.,
and Mills, G. B.
(1998)
J. Immunol.
161,
5404-5412[Abstract/Free Full Text]
|
| 35.
|
Yang, W. C.,
Ghiotto, M.,
Barbarat, B.,
and Olive, D.
(1999)
J. Biol. Chem.
274,
607-617[Abstract/Free Full Text]
|
| 36.
|
Mohamed, A. J.,
Nore, B. F.,
Christensson, B.,
and Smith, C. I. E.
(1999)
Scand. J. Immunol.
49,
113-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Gupta, N.,
Scharenberg, A. M.,
Fruman, D. A.,
Cantley, L. C.,
Kinet, J. P.,
and Long, E. O.
(1999)
J. Biol. Chem.
274,
7489-7494[Abstract/Free Full Text]
|
| 38.
|
Schaeffer, E. M.,
Debnath, J.,
Yap, G.,
McVicar, D.,
Liao, X. C.,
Littman, D. R.,
Sher, A.,
Varmus, H. E.,
Lenardo, M. J.,
and Schwartzberg, P. L.
(1999)
Science
284,
638-641[Abstract/Free Full Text]
|
| 39.
|
Shan, X. C.,
and Wange, R. L.
(1999)
J. Biol. Chem.
274,
29323-29330[Abstract/Free Full Text]
|
| 40.
|
Sommers, C. L.,
Rabin, R. L.,
Grinberg, A.,
Tsay, H. C.,
Farber, J.,
and Love, P. E.
(1999)
J. Exp. Med.
190,
1427-1438[Abstract/Free Full Text]
|
| 41.
|
Fluckiger, A.-C., Li, Z.,
Kato, R. M.,
Wahl, M. I.,
Ochs, H. D.,
Longnecker, R.,
Kinet, J.-P.,
Witte, O. N.,
Scharenberg, A. M.,
and Rawlings, D. J.
(1998)
EMBO J.
17,
1973-1985[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Bunnell, S. C.,
Diehn, M.,
Yaffe, M. B.,
Findell, P. R.,
Cantley, L. C.,
and Berg, L. J.
(2000)
J. Biol. Chem.
275,
2219-2230[Abstract/Free Full Text]
|
| 43.
|
Oda, A.,
Ikeda, Y.,
Ochs, H. D.,
Druker, B. J.,
Ozaki, K.,
Handa, M.,
Ariga, T.,
Sakiyama, Y.,
Witte, O. N.,
and Wahl, M. I.
(2000)
Blood
95,
1663-1670[Abstract/Free Full Text]
|
| 44.
|
Ching, K. A.,
Grasis, J. A.,
Tailor, P.,
Kawakami, Y.,
Kawakami, T.,
and Tsoukas, C. D.
(2000)
J. Immunol.
165,
256-262[Abstract/Free Full Text]
|
| 45.
|
Laffargue, M.,
Ragab-Thomas, J. M. F.,
Ragab, A.,
Tuech, J.,
Missy, K.,
Monnereau, L.,
Blank, U.,
Plantavid, M.,
Payrastre, B.,
Raynal, P.,
and Chap, H.
(1999)
FEBS Lett.
443,
66-70[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Hamazaki, Y.,
Kojima, H.,
Mano, H.,
Nagata, Y.,
Todokoro, K.,
Abe, T.,
and Nagazawa, T.
(1998)
Oncogene
16,
2773-2779[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Gaudry, M.,
Roberge, C. J.,
de Médicis, R.,
Lussier, A.,
Poubelle, P. E.,
and Naccache, P. H.
(1993)
J. Clin. Invest.
91,
1649-1655[Medline]
[Order article via Infotrieve]
|
| 48.
|
Kaukonen, J.,
Lahtinen, I.,
Laine, S.,
Alitalo, K.,
and Palotie, A.
(1996)
Br. J. Haematol.
94,
455-460[Medline]
[Order article via Infotrieve]
|
| 49.
|
Weil, D.,
Power, M.-A.,
Smith, S. I.,
and Li, C.
(1997)
Blood
90,
4332-4340[Abstract/Free Full Text]
|
| 50.
|
Varnai, P.,
Rother, K. I.,
and Balla, T.
(1999)
J. Biol. Chem.
274,
10983-10989[Abstract/Free Full Text]
|
| 51.
|
Baraldi, E.,
Carugo, K. D.,
Hyvonen, M.,
LoSurdo, P.,
Riley, A. M.,
Potter, B. V. L.,
OBrien, R.,
Ladbury, J. E.,
and Saraste, M.
(1999)
Structure Fold. Des.
7,
449-460[Medline]
[Order article via Infotrieve]
|
| 52.
|
Andreotti, A. H.,
Bunnell, S. C.,
Feng, S.,
Berg, L. J.,
and Schreiber, S. L.
(1997)
Nature
385,
93-97[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Guinamard, R.,
Fougereau, M.,
and Seckinger, P.
(1997)
Scand. J. Immunol.
45,
587-595[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Welch, H.,
Mauran, C.,
and Maridonneau-Parini, I. I.
(1996)
Methods (Orlando)
9,
607-618
|
| 55.
|
Kraft, A. S.,
and Berkow, R. L.
(1987)
Blood
70,
356-362[Abstract/Free Full Text]
|
| 56.
|
Shirai, T.,
Tanaka, K.,
Terada, Y.,
Sawada, T.,
Shirai, R.,
Hashimoto, Y.,
Nagata, S.,
Iwamatsu, A.,
Okawa, K., Li, S. W.,
Hattori, S.,
Mano, H.,
and Fukui, Y.
(1998)
Biochim. Biophys. Acta
1402,
292-302[Medline]
[Order article via Infotrieve]
|
| 57.
|
Siddiqui, R. A.,
and English, D.
(2000)
Biochim. Biophys. Acta
1483,
161-173[Medline]
[Order article via Infotrieve]
|
| 58.
|
Knall, C.,
Worthen, G. S.,
and Johnson, G. L.
(1997)
Proc. Natl. Acad. Sci., U. S. A.
94,
3052-3057[Abstract/Free Full Text]
|
| 59.
|
Niggli, V.,
and Keller, H.
(1997)
Eur. J. Pharmacol.
335,
43-52[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Xiao, Y. Q.,
Minami, K.,
Mue, S.,
and Ohuchi, K.
(1998)
Eur. J. Pharmacol.
360,
195-204[CrossRef][Medline]
[Order article via Infotrieve]
|
| 61.
|
Haribabu, B.,
Zhelev, D. V.,
Pridgen, B. C.,
Richardson, R. M.,
Ali, H.,
and Snyderman, R.
(1999)
J. Biol. Chem.
274,
37087-37092[Abstract/Free Full Text]
|
| 62.
|
Sasaki, T.,
IrieSasaki, J.,
Jones, R. G.,
OliveiradosSantos, A. J.,
Stanford, W. L.,
Bolon, B.,
Wakeham, A.,
Itie, A.,
Bouchard, D.,
Kozieradzki, I.,
Joza, N.,
Mak, T. W.,
Ohashi, P. S.,
Suzuki, A.,
and Penninger, J. M.
(2000)
Science
287,
1040-1046[Abstract/Free Full Text]
|
| 63.
|
Li, Z.,
Jiang, H.,
Xie, W.,
Zhang, Z.,
Smrcka, A. V.,
and Wu, D.
(2000)
Science
287,
1046-1049[Abstract/Free Full Text]
|
| 64.
|
Hirsch, E.,
Katanaev, V. L.,
Garlanda, C.,
Azzolino, O.,
Pirola, L.,
Silengo, L.,
Sozzani, S.,
Mantovani, A.,
Altruda, F.,
and Wymann, M. P.
(2000)
Science
287,
1049-1053[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Fumagalli, H. Zhang, A. Baruzzi, C. A. Lowell, and G. Berton
The Src Family Kinases Hck and Fgr Regulate Neutrophil Responses to N-Formyl-Methionyl-Leucyl-Phenylalanine
J. Immunol.,
March 15, 2007;
178(6):
3874 - 3885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Boulven, S. Levasseur, S. Marois, G. Pare, E. Rollet-Labelle, and P. H. Naccache
Class IA Phosphatidylinositide 3-Kinases, rather than p110{gamma}, Regulate Formyl-Methionyl-Leucyl-Phenylalanine-Stimulated Chemotaxis and Superoxide Production in Differentiated Neutrophil-Like PLB-985 Cells.
J. Immunol.,
June 15, 2006;
176(12):
7621 - 7627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Park, H.-Y. Lee, M.-K. Kim, E. H. Shin, S. H. Jo, S. D. Kim, D.-S. Im, and Y.-S. Bae
Lysophosphatidylserine Stimulates L2071 Mouse Fibroblast Chemotactic Migration via a Process Involving Pertussis Toxin-Sensitive Trimeric G-Proteins
Mol. Pharmacol.,
March 1, 2006;
69(3):
1066 - 1073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. G. Fernandes, G. Lachance, G. Pare, E. Rollet-Labelle, and P. H. Naccache
Signaling through CD16b in human neutrophils involves the Tec family of tyrosine kinases
J. Leukoc. Biol.,
August 1, 2005;
78(2):
524 - 532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mangla, A. Khare, V. Vineeth, N. N. Panday, A. Mukhopadhyay, B. Ravindran, V. Bal, A. George, and S. Rath
Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses
Blood,
August 15, 2004;
104(4):
1191 - 1197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Burelout, N. Thibault, S. Levasseur, S. Simard, P. H. Naccache, and S. G. Bourgoin
Prostaglandin E2 Inhibits the Phospholipase D Pathway Stimulated by Formyl-methionyl-leucyl-phenylalanine in Human Neutrophils. Involvement of EP2 Receptors and Phosphatidylinositol 3-kinase {gamma}
Mol. Pharmacol.,
August 1, 2004;
66(2):
293 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Haque, J. T. Fallon, J. J. Pan, M. B. Taubman, and P. C. Harpel
Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion
Blood,
February 15, 2004;
103(4):
1296 - 1304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, S. K. Shaw, S. Ma, L. Yang, F. W. Luscinskas, and C. A. Parkos
Regulation of Leukocyte Transmigration: Cell Surface Interactions and Signaling Events
J. Immunol.,
January 1, 2004;
172(1):
7 - 13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gilbert, S. Levasseur, P. Desaulniers, A.-A. Dusseault, N. Thibault, S. G. Bourgoin, and P. H. Naccache
Chemotactic Factor-Induced Recruitment and Activation of Tec Family Kinases in Human Neutrophils. II. Effects of LFM-A13, a Specific Btk Inhibitor
J. Immunol.,
May 15, 2003;
170(10):
5235 - 5243.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|